Conference Reports for NATAP

22nd Conference on Retroviruses and Opportunistic Infections Seattle Washington Feb 23 - 26, 2015 Back

Characterization of NNRTI & INI Resistance Mutations Observed in a Study Subject on Oral Two-Drug Maintenance Therapy with 10 mg Cabotegravir + 25 mg Rilpivirine       Reported by Jules Levin Intl Workshop in Antiviral Drug R esistance Feb 21-22, 2015, Seattle WA   Kathleen Dudas et al, GlaxoSmithKline, ViiV